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PURPOSE. To investigate by optical coherence tomography angiography (OCT-A) the choroidal
vascular response to experimentally increased blood pressure in patients with central serous
chorioretinopathy (CSCR).
METHODS. For this multicenter, observational, case-control study, we enrolled 35 patients with
an established diagnose of CSCR and 25 age-matched healthy controls. All subjects underwent
a handgrip isometric exercise to obtain elevation of blood pressure (BP). In the resting phase
and during the physical effort, macular OCT-angiograms were acquired. Systemic
hemodynamic data were recorded at baseline and during stress conditions using an
electronic sphygmomanometer. The analysis of vascular density (VD) of the choriocapillaris
(CC) was performed on OCT-angiograms. The results obtained in CSCR patients, both at
baseline and during the stress test, were compared with those of healthy subjects.
RESULTS. Baseline and under stress values of systolic BP, diastolic BP, and mean arterial pressure
were significantly higher (P < 0.05) in CSCR patients compared to controls, reaching values
in the range of hypertension during the exercise. Baseline VD values of the CC were
significantly lower (P < 0.05) in CSCR cases compared to healthy subjects. We noticed a
significant increase (P < 0.05) in these values under stress condition in CSCR patients and not
in controls.
CONCLUSIONS. The present study suggests that choroidal blood flow is dysregulated in CSCR.
During physical stress, CSCR patients easily reach critical values of BP that are not dampened
by compensatory mechanisms in the choroidal vessels, as it happens in healthy subjects. The
CC in CSCR could be particularly vulnerable to variations of systemic hemodynamics.
Keywords: OCT-Angiography, central serous chorioretinopathy, choroid, blood flow,
choriocapillaris
Central serous chorioretinopathy (CSCR) is a chorioretinaldisease characterized by an idiopathic neurosensory retinal
detachment at the posterior pole, often associated with focal
retinal pigment epithelium (RPE) detachments.1,2 It is usually a
self-limiting, benign disorder; however, it can become chronic
and result in a permanent visual deterioration due to foveal
atrophy.3–7
Choroidal vascular hyperpermeability and choroidal thick-
ening—revealed by indocyanine green angiography (ICGA) and
optical coherence tomography (OCT), respectively—suggest
that changes in the choroid may have a key role in the
pathophysiology of CSCR.8–10 In addition to dye leakage from
the inner choroid, ICGA shows a series of findings (including
vascular filling delays, venous congestion, and shifting of the
dye in the extravascular space) that testify to the presence of an
abnormal choroidal blood flow in patients affected by
CSCR.11–13 Within the thickened choroid, enhanced depth
imaging OCT and swept-source OCT reveal dilated choroidal
vessels and other structural alterations of the choroidal
architecture that further reinforce the concept of a link
between disturbances of choroidal circulation and CSCR.14,15
High levels of circulating catecholamines, endogenous hyper-
cortisolism, and exogenous corticosteroid administration have
been associated with an increased risk of CSCR.16–18 The
mechanisms through which they determine a functional
dysregulation of the choroidal vasculature are not yet clearly
defined.
Blood flow in the choroid is regulated by the autonomic
nervous system and by autoregulatory processes that seem to
be very efficient in this ocular vascular district.19
Several studies using laser doppler flowmetry have demon-
strated a rapid vascular regulation and adaptation of the human
choroid during dynamic changes of the ocular perfusion
pressure (OPP), obtained by experimental changes of the
intraocular pressure (IOP) or blood pressure (BP).20–22 Tittl et
al.23 observed that the subfoveal choroidal blood flow
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significantly increases in patients with a history of chronic
CSCR compared with control subjects during an increase of
the arterial BP provoked by an isometric exercise. The authors
suggested that a choroidal vascular dysregulation may have a
role in the pathogenesis of CSCR or may be a consequence of
the disease itself.23 This local choroidal hemodynamic impair-
ment in CSCR needs to be further characterized. The impact of
BP changes on the choroidal perfusion should be also
investigated, given that hypertension is often associated with
CSCR.24,25 Moreover, a type A personality and sympathetic
hyperactivity frequently characterize these patients, easily
leading to changes in systemic hemodynamics and OPP.26,27
New OCT technologies have substantially improved our
capability in qualitatively and quantitatively evaluating the
choroidal vasculature and perfusion.28,29 OCT-Angiography
(OCT-A), a recent label-free imaging modality that uses the
blood cells motion as contrast, is able to provide information
on the blood flow in the chorioretinal microvasculature.30,31 In
the present study, we used OCT-A to examine the choroidal
vascular response of patients with CSCR to an abrupt increase
of BP induced by isometric exercise. With a real-time
evaluation of the behavior of blood flow in the choriocapillaris
(CC), we looked for further confirmation that a dysfunctional




This case-control study was conducted at the Fondazione per la
Macula Onlus (Genova, Italy) and the Eye Clinic at S. Maria
Della Misericordia Hospital (Perugia, Italy).
Study patients and control subjects were examined by OCT-
A before and during isometric exercise with a handgrip test
(HGT) to evaluate the impact of an induced increase of BP and
OPP on the choroidal vascular hemodynamics. The study was
performed in accordance with the Declaration of Helsinki after
approval by the Genova and Perugia Institutional Ethics
Committees (IEC). Fully informed written consent was
obtained from all the study patients prior to the full
ophthalmologic examination and the HGT.
Study Population
Patients with a documented history of CSCR and age-matched
healthy controls were consecutively enrolled between Novem-
ber 2016 and November 2017. The initial diagnosis of CSCR
was made on the basis of the presence of one or more leaking
points on FA, choroidal vascular hyperpermeability on ICGA,
structural OCT findings including subretinal fluid, serous
pigmented epithelium detachments (PEDs), and choroidal
thickening. Not included in the study were eyes with any
amount of subretinal fluid accumulation, fibrovascular PEDs, or
any other retinal change in the central macula that could
influence OCT-A imaging of the examined choroid. Patients
showing serous retinal detachment outside the OCT-A scan-
ning area at the time of the examination were considered
eligible for the study. The CSCR cohort was then divided into
two different subgroups: active (A) or quiescent (Q) disease
based on the presence or absence of extramacular subretinal
fluid on structural-OCT scans. In case of bilateral history of
CSCR, with both eyes eligible for the study, the study eye was
randomly selected. CSCR patients with systemic hypertension
(defined as systolic BP higher than 150 mm Hg or diastolic BP
higher than 90 mm Hg at baseline) were not included in the
study for safety reasons. In addition, subjects were excluded if
they had refractive error of 3 diopters or more, peripapillary
choroidal dystrophy and staphyloma, established diagnosis of
glaucoma, previous ocular surgery or laser photocoagulation,
photodynamic therapy (PDT) in the previous 12 months and,
in any case, not followed by reactivation of the disease,
systemic steroidal therapy in the previous 6 months, or any
evidence of eye disease that might interfere with the purpose
of the study. Eyes with poor quality images on OCT-A (quality
index lower than 40) due to poor fixation or media opacities
that could confound the quantitative assessment were also
excluded. Healthy subjects with best-corrected visual acuity
(BCVA) of 20/20 or better and no history or clinical evidence of
retinal disease or relevant systemic illness were included in the
study as a control group. The entire study population
underwent BCVA testing, slit-lamp biomicroscopy, intraocular
pressure (IOP) baseline measurement, fundus evaluation,
structural OCT and OCT-A (at baseline and during the isometric
exercise).
Experimental Protocol
Subjects were asked not to ingest caffeine or alcohol in the 12
hours before the examination. After steady-state conditions
were reached, three BP measurements spaced 5 minutes apart
were taken using a portable electronic sphygmomanometer
(Omron Model M6; Omron Europe B.V., Hoofddorp, The
Netherlands). The automated oscillometric approach allowed a
range of measurements between 0 and 300 mm Hg of pressure
and between 40 and 200 heartbeats. The test accuracy was
about 3 mm Hg (armlet) and 5% (heartbeat). Insufflation was
automatic and the subject’s BP adapted, while an electronic
controlled valve effected disinflation. The clinical accuracy was
in accordance with the AAMISP10 auscultatory standard: 5 mm
Hg of systematic bias and 8 mm Hg of Standard Deviation (SD).
The sphygmomanometer wrist was set at the level of the heart
to avoid potential positioning bias.
After pupil dilation with 1% tropicamide (Visumidriatic,
Visufarma SpA, Rome, Italy) each patient underwent a baseline
OCT-A examination. This OCT-angiogram was set as reference
scan. The HGT was then executed using a Jamar hand
dynamometer (Lafayette Instruments, Lafayette, IN, USA) on
the dominant side, based on the American Society of Hand
Therapist recommendation. The patients were seated in a
comfortable position with elbow flexed at 908, shoulder
adducted, forearm and wrist in a neutral position.32 They
were instructed to squeeze the handle maximally and asked to
avoid undue pain. The mean of three measurements was
documented and a value equal to 30% of the maximal isometric
handgrip strength was computed. Each enrolled subject
performed the isometric handgrip exercise for 2.5 to 3 minutes
maintaining the 30% of the maximal strength value. At 1.5
minutes from the beginning of the exercise, an OCT-A was
started in the examined eye while systemic BP and heart rate
were measured. This second OCT-A was acquired as a follow-
up mode scan to maximize the superimposability of the two
examinations. At the end of the OCT-A, the HGT was
interrupted, and recovery of BP to baseline was checked in
the following minutes. Systolic BP (SBP), diastolic BP (DBP),
mean arterial pressure (MAP), and heart rate (HR) were
recorded. OPP was also calculated as 2/3 MAP  IOP.33
OCT-Angiography System Setup
The Spectralis OCT2 (Heidelberg Engineering GmbH, Heidel-
berg, Germany) was the 85 kHz Spectral Domain OCT device
used to obtain OCT-angiograms. Detailed features of the OCT-A
system have been previously described.34 A high resolution
OCT-A volume scan of 15 3 108 (approximately 4.5 3 3 mm)
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centered in foveal area was acquired in each enrolled subject.
The volume scan was made by 261 B-scans, and the automated
averaging process was set at 35 frames per scan (distance
between two consecutive B-scans of 11 lm). The OCT-A
software (Heyex Software Version 1.9.201.0; Heidelberg
Engineering) allowed visualization of angiograms both in C-
scan (‘‘en-face’’) or B-scan projections. For our purpose only, C-
scans were assessed. A maximum intensity projection algo-
rithm was chosen to highlight the highest value voxel along a
line of sight. In this way, all the structures showing a
decorrelation signal and, when actively perfused, were easily
detected.
The built-in software provides an automated segmentation
algorithm for the retinal and choroidal vascular layers.
Automated segmentation strategies were based on the capa-
bility of the device to distinguish different levels of reflectivity
between contiguous retinal and choroidal layers on structural
OCT. In the current study, we focused our investigation on the
CC. En-face angiograms of this layer were taken immediately
beneath the Bruch’s membrane (BM) with a 25 lm-thick
section whose boundaries were aligned on the BM’s profile.
Potential fails in segmentation strategies were carefully
checked on the B-scan projections. If segmentation errors
occurred, cases were excluded from the study.
A quantitative analysis of OCT-angiograms was performed to
detect flow, flow-void areas, and blood flow changes at the
level of the CC. The first step of this analysis was thresholding
the image with the Phansalkar method (radius of 15 pixels), a
specifically designed automated local thresholding algorithm
for low-contrast images.35 This process was obtained by
importing OCT-angiograms in FIJI, an available for free imaging
software (expanded version of ImageJ, Version 1.51h; Wayne
Rasband, National Institute of Health, Bethesda, MD, USA). The
thresholded images were then analyzed with the Analyze
Particles FIJI tool, which measured and computed all areas
greater or equal to 1 pixel where there was flow (decorrelated
pixels) information.36 The CC vascular flow density (VD) was
then computed as the ratio (expressed as percentage) between
the number of decorrelated pixels and the total number of
pixels composing the image. Quantitative data were obtained
from a 4 3 3 mm area (original image 4.5 3 3 mm area, 158 3
108) to minimize the effects of artifacts at the edge of the C-
scan. Each OCT-angiogram had a resolution of 784 3 520
pixels.
A qualitative assessment of the CC on baseline and HGT
OCT-angiograms was also performed to localize the perfusion
changes. The potential stress-induced changes were better
visualized with a subtraction protocol in the image calculator
tool of FIJI.
The two OCT-A imaging sessions (baseline and under stress
test) were performed by the same experienced operator (ML),
within a single visit. All scans were independently reviewed by
two investigators (FCP and ML) to ensure correct segmentation
and sufficient image quality for post hoc analysis.
Statistical Analysis
Quantitative variables were described by their mean and
standard deviation (SD). The absolute and the relative (ratio of
absolute difference and baseline value) differences between
baseline and under stress quantitative data were also reported.
The Shapiro-Wilk test was used to check whether the sample
came from a normally distributed population. Depending on
the statistical distribution, comparisons of means of indepen-
dent variables were performed using the Student’s t-test or the
Mann-Whitney test. The paired t-test or Wilcoxon-Mann-
Whitney test was used to compare paired data. The linear
regression analysis and the Pearson’s ‘‘r’’ or Spearman’s rank
correlation coefficient were used to measure the statistical
dependence of quantitative variables. A P value of <0.05 was
considered as statistically significant. All statistical analyses
were performed using the SAS System for Windows (release
9.4; SAS Institute, Inc., Cary, NC, USA).
RESULTS
Study Population
Fifty-seven eyes of 37 patients with an established diagnosis of
CSCR were consecutively evaluated in the two recruitment
centers. Fifteen eyes (26.3%) were excluded due to the
presence of subretinal fluid accumulation or fibrovascular
PEDs within the OCT-A scanning area, 2 eyes (3.5%) due to
poor image quality, 3 eyes (5.3%) due to high refractive error,
and 2 eyes (3.5%) due to baseline BP values in the range of
hypertension. Thirty-five eyes of 35 patients matching the
inclusion criteria, and 25 eyes of 25 age-matched healthy
subjects were enrolled in the study. The mean age of CSCR
patients was 48.4 6 7.6 years (range, 33–65 years) and the
mean age for controls was 42.9 6 8.3 years (range, 26–59
years). Two females were in the CSCR group (5.7%), and in the
control group (8%). The ethnicity was Caucasian in both
samples. Mean IOP values were 13.5 6 1.8 mm Hg in the CSCR
group and 14.6 6 1.9 mm Hg in the control group. Considering
the CSCR patients, 14 had active disease and 21 had a
quiescent condition. Fourteen eyes (40%) had history of PDT
followed by reactivation of the disease, 20 (57%) had
previously undergone a systemic steroidal therapy, and 6
(17%) were under treatment for systemic hypertension. None
of the control subjects reported any actual or previous
systemic therapy. No adverse events were reported during
the entire patient assessment. The simultaneous OCT-A
examination and the isometric handgrip exercise were well
tolerated by all participating subjects.
Hemodynamic Data
The mean and standard deviations of the SBP, DBP, MAP, and
OPP both at baseline and during the isometric exercise are
shown in Table 1. A statistically significant increase (P < 0.05)
between baseline and under-stress values was observed both in
CSCR and healthy subjects. Baseline and under-stress data were
significantly higher (P < 0.05) in CSCR patients compared with
controls. The absolute and relative differences (D and Dr)
between baseline and under-stress data of CSCR did not
significantly differ from those of healthy controls (Table 2).
Quantitative Imaging Analysis
Results of the quantitative assessment of the CC are shown in
Table 3. A statistically significant increase (P < 0.05) in terms
of VD was noticed in CSCR patients between baseline and
under-stress values. The baseline VD data were significantly
lower (P < 0.05) in CSCR compared to healthy controls. No
statistically significant differences were reported among
baseline and under-stress VD values in the control group and
between the two groups when considering under-stress data.
Absolute and relative VD variations (DVD CC) between
baseline and under-stress data were significantly higher in
CSCR patients than in healthy subjects (Table 4). A significantly
different response (P < 0.05) of CC-VD in CSCR patients
compared to controls was also detected in a post-hoc analysis
where we considered a CSCR subgroup (20 patients) with a
baseline CC-VD value homogeneous with that of healthy
subjects (CC-VD > 83%). Furthermore, a linear regression
analysis without intercepts was computed for both groups to
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give us a more accurate modeling of the phenomenon (Fig. 1).
The slopes for patients with CSCR and controls were
significantly different (P < 0.05) both for the entire samples
and for the subgroups with CC-VD > 83%.
No other statistically significant correlations between
hemodynamic changes and variations of OCT-A quantitative
parameters were observed. Moreover, no statistically signifi-
cant correlations were appreciated between corticosteroid
therapies or previous PDT and hemodynamic or OCT-A
quantitative findings. By considering the stratification of the
CSCR group for the presence (A) or absence (Q) of subretinal
fluid, a positive linear correlation was reported between OPP
and CC-VD variations among baseline and under-stress data
only in the Q sub-group. The absolute and relative variations of
MAP and OPP were significantly higher (P < 0.05) in Q cases
compared to A cases. No significant differences in terms of age
and sex were observed between A and Q cases. Instead a
statistically significant difference (P ¼ 0.002) was noted for
disease duration (77.3 months versus 122.2 months).
Qualitative Imaging Analysis
A complete review of the structural B-scans composing each
single OCT-A volume scan was performed by two experienced
examiners (FCP and ML). None of the analyzed cases showed
shadowgraphic artifacts that may have negatively influenced
the CC vascular flow assessment. At baseline, a less homoge-
neous pattern of the CC with prominent zones of reduced flow
signal characterized CSCR cases compared with controls. In
the same cases a certain rehash or increase of the CC flow
signals was seen in the OCT-angiograms taken during HGT (Fig.
2). Large areas of flow voids visible in CSCR patient at baseline
appeared reduced. The differential images showed that the
new signals of blood flow were distributed diffusely in the
examined area of CC. In the control group, the same images of
the CC revealed few and widely spread new signals of
decorrelation indicating a minimal or virtually absent increase
of blood flow.
DISCUSSION
In the present study, we used OCT-A to investigate the
choroidal vascular response to an abrupt elevation of the
systemic BP in patients with CSCR. An increase of blood flow
in the CC was obtained in these patients but not in a control
group of healthy subjects. Our findings suggest that the
physiological mechanisms controlling the homeostasis of
choroidal circulation during hemodynamic stress may be
dysregulated in CSCR.
Blood flow is driven in the choroidal vessels by the OPP, a
positive pressure depending on the systemic BP and the IOP
that opposes it. We experimentally increased the systemic BP,
and consequently the OPP, through an isometric handgrip
exercise that produces active stimulation of the sympathetic
system through activation of mechanoreceptors during the
increased muscle tension.37–39 During this stress condition,
there was a significant increase of SBP, DBP, MAP, HR, and OPP
in both groups of the study. The baseline values of SBP and
DBP were significantly higher in patients with CSCR; during
the exercise, they reached values definitely in the range of
hypertension (mean SBP¼ 165.57 mm Hg, mean DBP¼ 105.60
mm Hg). The under-stress values of BP in controls were
significantly lower (mean SBP ¼ 143.44 mm Hg, mean DBP ¼
97.24 mm Hg). Hypertension is already considered to be a risk
factor for CSCR.24,25 Our findings show that also in absence of
a basal hypertension patients with CSCR, more than healthy
subjects, may reach frank hypertensive values in occasion of
physical stress. A dysfunction of the autonomic nervous system
is widely recognized in people affected by CSCR.27 Compared
to healthy subjects, CSCR patients have a higher sympathetic
tone, associated with type A personality, easy emotional stress,
and high levels of catecholamines in the blood.16,26 Psycho-
logical stress and increased BP are found strictly linked in
people with sympathetic hyperactivity.40 Our findings contrib-
ute to recognize a hemodynamic instability in patients with
CSCR for whom physical efforts, as well as emotional stress,
may produce significant BP variations and episodic hyperten-
sion. In addition to a high sympathetic activity, patients with
TABLE 2. Absolute and Relative Differences Between Baseline and Under-Stress Values in Terms of Hemodynamic Findings in CSCR Patients and
Healthy Controls
CSCR Patients Healthy Controls
P Value CSCR vs.
Controls (D)














SBP 38.63 6 15.28 31.0% 6 13.3% 31.24 6 9.21 28.0% 6 8.3% 0.0541 0.3880
DBP 22.26 6 8.94 27.2% 6 11.7% 22.12 6 6.00 29.7% 6 8.4% 0.7354 0.2749
HR 17.66 6 11.61 26.3% 6 17.9% 22.40 6 9.59 32.5% 6 14.0% 0.0733 0.0795
MAP 27.71 6 10.43 28.8% 6 11.8% 25.16 6 6.57 29.0% 6 7.8% 0.4903 0.7997
MOPP 18.48 6 6.95 33.6% 6 14.3% 16.77 6 4.38 35.0% 6 9.8% 0.4700 0.5411
TABLE 1. Hemodynamic Findings in CSCR Patients and Healthy Controls at Baseline and During the Isometric Handgrip Exercise




















SBP 126.94 6 11.62 165.57 6 16.41 <0.0001 112.20 6 7.70 143.44 6 10.95 <0.0001 <0.0001 <0.0001
DBP 83.4 6 7.91 105.60 6 10.68 <0.0001 75.12 6 5.35 97.24 6 7.12 <0.0001 <0.0001 0.0059
HR 70.29 6 8.61 87.94 6 11.15 <0.0001 69.68 6 6.79 92.08 6 10.99 <0.0001 0.8929 0.1011
MAP 97.88 6 8.60 125.59 6 11.46 <0.0001 87.48 6 5.89 112.64 6 7.71 <0.0001 <0.0001 <0.0001
OPP 56.24 6 5.92 74.72 6 7.53 <0.0001 48.59 6 4.69 65.36 6 5.38 <0.0001 <0.0001 <0.0001
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CSCR seem to have a reduced sympathetic reactivity. Tewari et
al.,41 by evaluating their systemic hemodynamic changes
during various stressor stimuli, including HGT, reported a
low response of the DBP, considered to be a sign of poor
sympathetic reactivity. In accordance with these findings, we
observed a trend toward a lower percent-increase of DBP in
our study patients during the stress test. However, to
characterize in detail the autonomic cardiovascular reaction
to a stress condition in patients with CSCR is beyond the scope
of the present study. Our aim was rather to investigate the end-
organ (choroidal) response to the sympathetic stimulation in
these patients.
The increased BP consequent to emotional and physical
stress situations tends to produce peripheral vascular hyper-
perfusion that is prevented in normal subjects by vasocon-
striction induced by sympathetic stimulation and, if present, by
local autoregulatory systems. A series of studies show that
choroidal vasculature has intrinsic control mechanisms able to
adjust the blood flow reaching the CC when OPP changes.20–22
Data by Tittl et al.,23 using the squatting isometric test to
increase BP and OPP, and laser doppler flowmetry to measure
the CC blood flow, indicate that this regulatory capacity of the
choroid fails in patients with CSCR. Using the HGT to produce
a hemodynamic stress and quantitative OCT-A to evaluate
changes in the CC blood flow, we obtained results leading to
the same conclusion, even if several differences between the
two studies must be underlined. While the Tittl study23
concerned the CC strictly corresponding to the foveal
avascular zone, our OCT-A analysis extended the evaluation
to a larger area of the macular CC (4 3 3 mm), showing the
presence of a wide choroidal dysregulation. Moreover, our
OCT-A acquisition was obtained during the actual physical
effort, whereas in the Tittl report, the laser doppler flowmetry
was obtained soon after the isometric exercise. They observed
that choroidal blood flow reached a twofold increase in CSCR
patients compared to controls.23 In our study, a mean of 3.2%
(4% in terms of relative difference) increase (P < 0.05) of CC-
VD was detected in CSCR patients, against a non-significant
change of CC-VD in controls. The percent of variations of CC
blood flow in the two studies are not comparable since they
refer to different vascular indicators of blood flow—albeit both
methods evaluate changes of blood cells motion in a vascular
tissue. With laser doppler flowmetry changes of the CC blood
flow velocity were measured with an arbitrary scale. With the
OCT-A we used the CC-VD values as indicators of choroidal
blood flow in the examined area. We quantified the percent
increase of detectable perfused microvascular network as
consequence of increased blood flow velocity. Some areas of
non-detectable CC blood flow at baseline in CSCR patients,
showed decorrelated signals during the experimentally in-
duced elevation of the OPP, indicating an increased perfusion.
This change should not happen in a functionally normal
choroid, where a reactive arteriolar vasoconstriction in the
Sattler and Haller layers would protect the CC against
overperfusion when BP suddenly increases.20–24 The virtually
stable values of CC-VD in the control group when OPP
increased confirm the presence of choroidal regulatory
mechanisms in healthy subjects. In terms of increase of CC-
VD and ratio between baseline and under-stress VD values, the
significant difference between controls and a subset of CSCR
patients (CC-VD >83%) confirmed the abnormal vascular
response in CSCR. Given that perfusion density of the CC
necessarily cannot increase beyond a certain threshold, our
measurements may be affected by a ceiling effect. Neverthe-
less, a different behavior in vascular changes between the two
groups is evident when comparing the slopes of linear
regression analysis without intercepts. These findings are also
compatible with a dysregulation in CSCR patients that prevents
the CC from reaching the same perfusion observed in normal
subjects at rest.
By comparing the effects of the stress test on subgroups for
active or inactive CSCR, we observed that variations of MAP
and OPP were significantly higher in the latter condition.
Moreover, only inactive cases had a positive linear correlation
between OPP and CC-VD variations, that should reflect a more
severe impairment of choroidal blood flow regulation.42 The
two groups (A and Q) were homogeneous for age and sex,
while disease duration was significantly longer in the inactive
group. In these patients, the long-standing disease is consistent
with a more advanced dysfunction of choroidal circulation and
more subjection to hemodynamic variations.
The CC imaged by OCT-A usually shows areas of impaired
flow signal whose extension increases with age.43 ‘‘Low-flow
signals,’’ ‘‘flow rarefaction areas,’’ and ‘‘flow-voids’’ at the CC
layer on OCT-angiograms have been recently described in
CSCR.44,45 Our OCT angiographic findings at baseline are
consistent with the observations of these studies, suggesting
slow blood flow or stasis in some districts of the CC in CSCR
patients. With OCT-A, Chan et al.46 conversely observed high
signal intensity and dilated CC vessels in most eyes with
TABLE 4. Absolute and Relative Differences Between Baseline and Under-Stress Values in Terms of Choriocapillaris Vascular Density in CSCR
Patients and Healthy Controls
CSCR Patients Healthy Controls
P Value CSCR vs.
Controls 6 (D)














CC vascular density 0.03 6 0.03 4.0% 6 3.6% 0.00 6 0.01 0.1% 6 0.7% <0.0001 <0.0001
TABLE 3. Quantitative OCT-Angiography Assessment of Choriocapillaris Vascular Density in CSCR Patients and Healthy Controls at Baseline and
During the Isometric Handgrip Exercise






















82.7% 6 5.2% 85.9% 6 3.7% <0.0001 86.9% 6 2.5% 86.8% 6 2.5% 0.6584 0.0006 0.3880
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clinically diagnosed CSCR; however, the images of their cases
also showed flow void areas in the CC. Ultimately, a blood flow
impairment that could be segmentary and different in various
districts seems to characterize the CC in CSCR.
Previous studies have investigated the choroidal response to
stress tests in healthy subjects and in CSCR patients by
measuring the choroidal thickness with Spectral Domain OCT
and enhanced depth imaging.47,48 Alwassia et al.47 did not
obtain any significant change in choroidal thickness during an
acute increase of systolic BP in healthy subjects. Roybal et al.48
observed an increase of choroidal thickness as a response to
increased BP in patients with CSCR but not in healthy controls.
These observations converge with our findings, supporting the
hypothesis of a compromised regulatory mechanism of
choroidal blood flow in CSCR.
It has been hypothesized that in patients with CSCR,
psychological stress and abnormal sympathetic activity may
interfere with choroidal blood flow through a local neural
dysregulation or by inducing dysfunction of the endothelial
related autoregulation.24 A failure of myogenic regulatory
mechanisms could be also involved since they seem to have
a major role in the instantaneous vascular response to BP
changes.37 In fact, only a prompt compensatory choroidal
reaction can explain insignificant blood flow changes detected
in the CC of our healthy subjects during physical effort.
Activities involving isometric muscle stress, such as the
HGT used in the present study, are performed daily by people
in the age range in which CSCR usually manifests itself. We can
speculate that the hemodynamic consequences of these
activities, when repetitive and prolonged, may not be
negligible in patients with CSCR. For these patients, the
impact of sustained isometric efforts on the circulatory system
and organ hemodynamics could be accentuated.49 Further-
more, tendency to BP variability and episodic hypertension
seems to have worse cardiovascular consequences and end-
organ damage than does stable hypertension.50 Accordingly,
the choroidal vascular system could suffer from continuous
changes of the systemic BP and OPP in absence of the
corresponding adjustments of blood flow by well-functioning
regulatory mechanisms.
Our observations suggest consideration of a pathological
model of CSCR where various risk factors for this disease may
have the common denominator of a significant impact on the
systemic or local choroidal hemodynamics. In this model, an
increased BP and OPP would not find adequate mechanisms of
vascular response and organ protection in the choroid. That
said, the hemodynamic changes could produce, in the long
run, a progressive choroidal vascular dysregulation. Low values
of IOP, a trend observed in CSCR cases of the present study,
have been already called in cause by one of us (FCP) as a
favoring factor for active CSCR.51 In a hemodynamic pathoge-
netic model of CSCR, low IOP may have a role by contributing
to elevation of OPP, as well as by increasing the transmural
pressure that drives fluid out of the CC.
A sizable amount of literature has associated the use of
corticosteroids and endogenous hypercortisolism with
CSCR.17,18 How corticosteroids induce exudative manifestation
or exacerbation of the disease is still unclear. Recently, Daruich
et al., supported by therapeutic results using antagonists of
mineralocorticoid receptors, hypothesized a key role of over-
FIGURE 1. (A–D) relationship between baseline (x-axis) and under-stress (y-axis) vascular density (VD) values and its inverse (100-VD) in CSCR
patients and healthy controls. (A, B) VD values of CSCR patients are referred to the entire sample. (C, D) VD values of CSCR patients are referred to
a baseline VD comparable with controls (CC-VD >83%).
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activation of this vascular receptor’s pathway in the pathogen-
esis of CSCR.52 Mineralocorticoids, as well as glucocorticoids,
may promote the rise of BP,53 contributing to hemodynamic
changes that favor CSCR. However, their major impact on this
disease suggests a direct action on the choroid, with a site-
specific response that has the potential for both vasoconstric-
tion and vasodilation.54 On this matter, little information can be
drawn from our study since it did not include patients who
were assuming corticosteroids or had endogenous hypercorti-
solism. We have not observed a different behavior of CC blood
flow in those who had been previously exposed to these
hormones with respect to the rest of the sample.
Limitations of the present study include the use of a
prototype device. VD measurements are used to evaluate the
extension of a vascular network on a given area and at a certain
depth. Nevertheless, we are aware that the lateral resolution (6
lm) and sampling intervals of the 158 3 108 area (11 lm)
associated with the maximum intensity projection algorithm,
might result a potential overestimation of the VD.34 Other
limitations may be related to the inhomogeneity of the study
patients, some of whom had actual subretinal exudation (even
if outside the analyzed area) while others had only history of
active disease. Furthermore, some of them had been treated in
the past with PDT or had taken corticosteroids. We assumed
that a basic disturbance of choroidal circulation could
characterize these patients in any case, as indeed it was
detected. Moreover, the subgroup evaluation excluded condi-
tioning the results by those factors. The quantitative analysis of
the blood flow in the CC performed in the present study was
aimed to investigate if there was a different response of CSCR
patients and healthy subjects to an episodic elevation of blood
pressure. This was significantly detected, showing that
choroidal blood flow is dysregulated in CSCR. However,
defining the degree of this dysregulation, and its relationship
to clinical variables, may need further investigation that
include repeatability and variability evaluations. More defined
disease stages without factors of potential bias should be also
considered in future studies. Then again, investigation on the
choroidal vascular reactivity to hemodynamic stress—and
consequently on the efficiency of choroidal blood flow
regulation—could be extended to other clinical conditions
having pachychoroid as common characteristic.55
In conclusion, we used OCT-A to evaluate the real-time
choroidal vascular reactivity to a systemic hemodynamic stress
in patients with CSCR as compared with normal subjects. In
this study, isometric exercise experimentally reproduced
hypertensive episodes that frequently occur in everyday life,
particularly in individuals with a higher sympathetic tone such
as those affected by CSCR. Our results indicate that mecha-
nisms regulating blood flow in the choroidal vessels might be,
or progressively become, inefficient in CSCR, leaving this
vascular district not sufficiently protected from sudden and
repeated hemodynamic stresses. Using a new technology to
analyze choroidal blood flow and a classic stress test to
experimentally increase BP, this study confirms the role of a
choroidal vascular dysregulation in the pathophysiology of
CSCR. We suggest that the choroid of patients with this disease
may have a peculiar vulnerability to systemic hemodynamic
changes and represent a target-organ for damage by hyperten-
sion.
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